Alteogen (South Korea)

Recent papers from Alteogen (South Korea)

1. Oral glycoside supplement (triterpenoid saponins) for early and intermediate stage age-related macular degeneration (SAMADI trial): study protocol for a double masked randomised placebo-controlled feasibility trialPilot and Feasibility Studies · 2026
2. The Safety, Tolerability, and Pharmacokinetics of ALT-BB4 (A Novel Recombinant Hyaluronidase): A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study in Healthy VolunteersDermatology and Therapy · 2025
3. Triterpenoid saponin–mediated recovery of visual deficits in age-related macular degeneration (AMD): Double-blind, placebo-controlled, randomised clinical trialAsia-Pacific Journal of Ophthalmology · 2025
4. Cryo‐ EM Structure of Human Hyaluronidase PH ‐20Proteins Structure Function and Bioinformatics · 2024
5. 6459 A Novel Long-Acting GH Receptor Antagonist Optimizing Therapeutic Efficacy and DurationJournal of the Endocrine Society · 2024
6. Morphology and distribution of antennal sensilla of Plautia stali (Hemiptera: Pentatomidae)Entomological Research · 2024
7. Toxicity of the recombinant human hyaluronidase ALT-BC4 on embryonic developmentJournal of Animal Science and Technology · 2021
8. Role of the P2 residue of human alpha 1-antitrypsin in determining target protease specificityPLoS ONE · 2017
9. Novel AGLP-1 albumin fusion protein as a long-lasting agent for type 2 diabetesBMB Reports · 2013